gabapentin · Crystal

What changed in the last 90 days

Every detected change for gabapentin, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Anti-epileptic Agent, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• valproate sodium· in shortage
• divalproex sodium d/r· 1 maker
• divalproex sodium er· 1 maker
• lamotirigine· 1 maker
• lamotrigine chewable dispersible· 1 maker
• lamotrigine extended release· 1 maker
• lamotrigine er· 2 makers
• methsuximide· 3 makers
• extended phenytoin sodium· 4 makers
• lamotrigine extended-release· 4 makers
• tiagabine hydrochloride· 6 makers
• fosphenytoin sodium· 12 makers

Common questions

Is Gabapentin in shortage right now?

No. FDA does not currently list Gabapentin in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Gabapentin?

128 companies have marketed Gabapentin in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

What does Gabapentin cost?

The typical pharmacy pays about $0.0400 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.